PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную микробиологию, биополимеры, биотопливо и продукты питания нового поколения, сообщил глава Минпромторга Антон Алиханов.

Russia plans to reduce its dependence on imports of critical biotechnological components—such as enzymes, starter cultures, and certain types of protein products—by at least half by 2030. This was stated by Russia’s Minister of Industry and Trade, Anton Alikhanov, in an interview with TASS.

“By 2030, we plan to cut import dependence on critically important biotechnological components—enzymes, starter cultures, and certain protein products—by at least twofold,” the minister said.

In addition, the strategy for the development of the bioeconomy sector aims to create new markets, including synthetic biology, industrial microbiology, biopolymers, biofuels, and next-generation food products, Alikhanov noted.

Another objective is to position Russia among the world’s leading suppliers of high value-added products from deep processing. This will involve expanding non-resource exports and creating new high-tech jobs, the minister added.

The development of the bioeconomy in Russia and the application of biotechnology across economic sectors will be discussed at the Future Technologies Forum, which will take place in Moscow on February 25–26. The main theme of this year’s forum is “Bioeconomy for People.”

Source: TASS, February 10, 2026.

Current news

  • March 10, 2026

    Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025

    Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26%…

  • March 10, 2026

    Retail Pharmaceutical Market Value Increased by 13.3% in 2025

    The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a…

  • March 10, 2026

    New Molecules Synthesized in Russia for Next-Generation Medicines

    The compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service…

  • March 10, 2026

    DSM Group Presents Top 10 Russian Pharmaceutical Distributors

    According to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87…

  • March 10, 2026

    Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

    The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную…

LLC “BioJet”. all rights reserved

  • Legal information